← All tickers

Is ERAS Worth Buying in 2026?

Erasca, Inc. Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-07-26

Here’s whether Erasca, Inc. Common Stock (ERAS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+13.59% over 10 days); RSI 51 — healthy momentum range; strong 1-year return of +1017.5%. Concerns: 3-month momentum negative (-11.1%). Currently 21.3% off its 52-week high. Score: +5/7.

Ready to act on this? 📈 Trade on Webull

ERAS is in a confirmed uptrend, trading above both its 50-day ($15.19) and 200-day ($10.51) moving averages. An RSI of 51.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +1017.5% compares to +16.5% for SPY (beat the market by 1001.1%). The current 21.3% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $111,754 today
vs. S&P 500 (SPY) — same period beat market by 1001.1%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($10.51)
✓Above 50-day MA ($15.19)
✓RSI(14) neutral zone (30–70) — currently 51.3
✓Positive return (+1017.5%)
!Within 10% of period high (−21.3%)
Period Range $19.11
$1.33 $24.28
RSI (14) 51.3
0 · OversoldOverbought · 100

Key Metrics

Price$19.11
Period Return+1017.5%
Period High$24.28
Period Low$1.33
Drawdown−21.3%
MA-50$15.19
MA-200$10.51
RSI (14)51.3
Avg Volume (30d)5.6M
vs. SPYbeat by 1001.1%
Return Rank#1 of 999

Trade ERAS

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers